Corcept Therapeutics Incorporated CORT
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Corcept Therapeutics Incorporated is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing medications that address severe endocrine, metabolic, oncologic, and neurologic disorders. The company’s core scientific approach is based on modulating the effects of the hormone corti…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees500
TickerCORT
Statistics
Market Cap$8.99B
Revenue (TTM)$761.4M
Net Income$99.7M
Net Margin13.1%
EPS$0.82
P/E223.20
P/S10.90
P/B13.14
EV/EBITDA-1161.90
ROE7.2%
Dividend Yield—
Price$83.78
Data: Twelve Data · Revenue = mcap / P/S